Arkolith/Insider Trading/FWBI/Form 4

Sapirstein James

President and CEO, DirectorFirst Wave BioPharma, Inc. (FWBI) · full profile →Form 4 · filed Oct 6, 2023
Net Selling
Open-Market Buys
$0
Open-Market Sells
$802
Net Open-Market Flow
-$802
Transactions
1
1 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Oct 4, 2023Sell(S)3K$0.29$80233K

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-23-107481) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML